Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Open-market sale CHIEF MEDICAL OFFICER sold 3,034 shares at $5.77 ($17,506)
  2. 4 Open-market sale Trachtenberg Eric sold 2,452 shares at $5.77 ($14,148)
  3. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,452 shares at $5.77 ($14,148)
  4. 4 Open-market sale CHIEF OPERATING OFFICER sold 2,911 shares at $5.77 ($16,796)
  5. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,586 shares at $5.77 ($43,771)
  6. 4 Grant or award Director acquired 20,000 shares (grant or award)
  7. 4 Grant or award Director acquired 20,000 shares (grant or award)
  8. 4 Grant or award Director acquired 20,000 shares (grant or award)
  9. 4 Grant or award Director acquired 20,000 shares (grant or award)
  10. 4 Grant or award Director acquired 25,000 shares (grant or award)
  11. 4 Grant or award Director acquired 20,000 shares (grant or award)
  12. 4 Other acquisition Director acquired 1,687,709 shares (other)
  13. 4 Exercise or conversion Chief Scientific Officer acquired 9,500 shares (option exercise)
  14. 4 Exercise or conversion Chief Scientific Officer acquired 47,000 shares (option exercise)
  15. 4 Grant or award Chief Medical Officer acquired 27,500 shares (grant or award)
  16. 4 Grant or award Chief Scientific Officer acquired 22,666 shares (grant or award)
  17. 4 Grant or award Trachtenberg Eric acquired 22,666 shares (grant or award)
  18. 4 Grant or award Chief Operating Officer acquired 27,500 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 76,000 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 22,666 shares (grant or award)

Page 8 of 15 · 288 filings